Biohaven Stock Down Fund's Turnaround Bet Sparks Hope
A patient biotech story gets a glimmer of hope as One Fund reveals a new $6 million stake in Biohaven. Here’s what th...
Learn what to ask a retirement planning expert to maximize your financial potential. Equip yourself with the right questions for success.
14,117 articlesA patient biotech story gets a glimmer of hope as One Fund reveals a new $6 million stake in Biohaven. Here’s what th...
Coal stocks moved higher as energy markets tensed. This piece breaks down why peabody energy other coal names jumped,...
As biotech earnings season unfolds, Precigen (PGEN) 2025 earnings take center stage. This guide breaks down what to m...
The crypto market kicked off 2026 with volatility, but three tokens jumped 25% or more. Dive into what drove these ga...
When headlines threaten to derail a stock you own, smart investors don’t panic. This guide explains how to evaluate M...
Upstart’s growth engine faces higher costs that squeeze margins, triggering a drop in price even when revenue beats. ...
AI investing is about balance: a pure data-analytics play versus an autos-and-hardware powerhouse. This article compa...
Meta stock has shown dramatic moves, creating opportunities and risks for investors. This guide breaks down how to ev...
This deep-dive breaks down Saga's Q1 2026 earnings, what the results mean for guidance, and how investors can score 2...
What could happen to NuScale Power stock over the next five years? This article breaks down the catalysts, scenarios,...
The AI race keeps evolving, and Alphabet sits at the center. A rumored Anthropic cloud deal hints at how hyperscale i...
A new proposal aims to end blind signing in Ethereum wallets. The change could reduce scam losses and tighten securit...